How big is the Vaccine Adjuvants Market?

The Vaccine Adjuvants Market size is expected to reach USD 2.11 billion in 2024 and grow at a CAGR of 12.97% to reach USD 3.89 billion by 2029. Read More

What is the current Vaccine Adjuvants Market size?

In 2024, the Vaccine Adjuvants Market size is expected to reach USD 2.11 billion. Read More

Who are the key players in Vaccine Adjuvants Market?

Adjuvatis, Merck KGaA, GlaxoSmithKline plc, Novavax Inc. and Croda International plc are the major companies operating in the Vaccine Adjuvants Market. Read More

Which is the fastest growing region in Vaccine Adjuvants Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Vaccine Adjuvants Market?

In 2024, the North America accounts for the largest market share in Vaccine Adjuvants Market. Read More

What years does this Vaccine Adjuvants Market cover, and what was the market size in 2023?

In 2023, the Vaccine Adjuvants Market size was estimated at USD 1.87 billion. The report covers the Vaccine Adjuvants Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vaccine Adjuvants Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Vaccine Adjuvants Market Report | Industry Analysis, Size & Forecast

Vaccine Adjuvants Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Vaccine Adjuvant Manufacturers is Segmented by Product Type (Mineral Salt-Based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-Derived Adjuvants, Virus-Like Particles (VLP), and Other Types), Usage Type (Active Immunostimulants, Carriers, and Vehicle Adjuvants), Disease Type (Infectious Disease and Cancer), Application (Research Applications and Commercial Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). the Market Size and Value (in USD) for the Above Segments.

Vaccine Adjuvants Industry Overview

The vaccine adjuvants market is consolidated in nature due to the presence of a few companies operating globally and regionally. The strategic initiatives taken by various governments to improve immunization and research and development for vaccine development by market players are propelling the market growth. The companies in the market include Adjuvatis, GlaxoSmithKline PLC, Croda International PLC, Merck KGaA, and Novavax Inc., among others.